PITTSBURGH, January 19, 1996 — Victor Vogel, M.D., M.H.S., will lead a newly established joint breast cancer program of the University of Pittsburgh Cancer Institute (UPCI) and Magee-Womens Hospital. Dr. Vogel comes to Pittsburgh from the University of Texas M.D. Anderson Cancer Center, where he was instrumental in implementing one of the most successful breast cancer chemoprevention programs in the nation.
"Dr. Vogel is a perfect choice for integrating the excellent research and clinical services provided by both institutions," said Ronald B. Herberman, M.D., director of the UPCI, Hillman Professor of Oncology and associate vice chancellor for research, Health Sciences, University of Pittsburgh. "His recognized service to women and his research on breast cancer prevention will contribute enormously to our National Cancer Institute-funded comprehensive breast cancer program."
"Magee-Womens Hospital has an established comprehensive breast care program that addresses the prevention, detection and treatment of breast cancer, as well as genetic counseling which analyzes and assesses risk for concerned women and their families," said Irma Goertzen, president and CEO, Magee-Womens Hospital. "By joining our expertise with that of the UPCI we offer the community one unified system, building upon the strengths of both while eliminating the duplication of services. Better use of our resources permits us to concentrate on research vital to the discovery of more effective treatment options."
As director of the joint program, Dr. Vogel will coordinate the integration of breast cancer services including risk assessment, genetic counseling, cancer prevention, imaging and other screening and diagnostic procedures, pathology, endocrinology, molecular epidemiology, medical oncology, radiation oncology, surgery and research.
"We are closing one chapter in breast cancer treatment with currently available therapies and opening a new chapter that will provide more targeted therapies, identify candidates for therapy earlier so that the disease is more manageable, and identify a woman's predisposition to breast cancer," added Dr. Vogel, who is joining the University of Pittsburgh also as a professor of medicine and epidemiology.
"One of the most important missions of this program will be to enhance the delivery of care to women who face barriers, including women who are older, impoverished or live in rural areas," he noted. "Another service we want to implement more broadly is counseling about breast cancer risk for concerned women and their families."
At the M.D. Anderson Cancer Center, Dr. Vogel was responsible for recruiting the largest number of women onto the Breast Cancer Prevention Trial, the national study designed to determine the worth of the anti-cancer drug tamoxifen in preventing breast cancer in women at high risk for the disease.
"Through ongoing research, we hope to develop additional chemoprevention strategies against breast cancer," said Dr. Vogel.
One of 26 National Cancer Institute-designated comprehensive cancer centers, the UPCI was established in 1984 through the joint efforts of a consortium consisting of the University of Pittsburgh, Carnegie Mellon University, the hospitals of the University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh and Magee-Womens Hospital. The UPCI's primary mission is to advance the understanding of cancer and to develop and provide innovative methods for cancer prevention, diagnosis, treatment and care. It is internationally recognized for basic and clinical research in biological therapies to treat cancer.
Magee-Womens Hospital is the obstetric, gynecologic and reproductive sciences specialty hospital affiliated with the University of Pittsburgh Medical Center and the teaching hospital for the University of Pittsburgh School of Medicine. Magee-Womens Hospital specializes in comprehensive care for women throughout their lives. Services include obstetrics, gynecology, neonatal intensive care, gynecological oncology, uro-gynecology, infertility evaluation and treatment and clinical genetics. The hospital maintains one of the largest breast cancer screening programs in the nation.
The Magee-Womens Research Institute is the nation's only research facility dedicated to women's and neonatal health issues.